Plain-English translation of NCT06333990 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether quetiapine, a single medication, can effectively treat symptoms of mild traumatic brain injury and trauma-related stress in veterans. Currently, many patients take multiple medications to manage these overlapping symptoms. This study compares using the medication alone against the standard approach of taking multiple medications together.
Many veterans with brain injuries end up taking several medications at once, which can be complicated, expensive, and cause unwanted side effects. Researchers want to know if this single medication could work just as well while simplifying treatment and reducing the burden on patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either take the new medication (with your other medications gradually stopped) or continue your current medication plan. Over the same time period, a study team will monitor how you're doing, adjust doses as needed, and measure whether your symptoms improve. You'll visit the study site regularly so researchers can track your progress and safety.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States